Despite headwinds from interest rate normalisation and yen depreciation pressures, Japanese life insurers continue to demonstrate sound fundamentals and broadly stable premium levels.
Despite a sharp drop in market share and competitive pressures, Helia’s capital, earnings, and strategy remain supportive of the rating in the near term.
The Indian reinsurer’s return on equity rose to 9.2% in FY 2025 on stronger investment income, but elevated COR kept underwriting performance in the red.
Ratings for nine insurers—including China Life and PICC P&C—affirmed, but negative outlook reflects pressures from market volatility and potential weakening of state support.
AM Best maintains 'Stable' outlook for non-life market, spotlighting prospects for motor and health, which are balanced by economic and underwriting challenges.
